{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Singapore Drug Manufacturers - Specialty & Generic news", "home_page_url": "https://sharemaestro.com/newsreel/sg/healthcare/drug-manufacturers-specialty-generic/", "feed_url": "https://sharemaestro.com/newsreel/sg/healthcare/drug-manufacturers-specialty-generic/feed.json", "description": "Latest Drug Manufacturers - Specialty & Generic company headlines from Singapore, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:8c16d13b42895a1f851bcd8a4534ee5f983c766f82b09bd5dcc73d68b63cfc84", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQWnYzSjd3eWlsYTNJWVJ5NjZ1aEpBNWt4aDNFb3lGYi1PZ0w5UFlWQ2R4TU5BNTFfWC1DRUZKNnl3R29TaGZReFp2NUlmNXh4Vm5qbWxuU0EyY3h5OV9sXzhOZ0ljYnhqYWhMcGNXSXBIajZpQnE2aUhDTkRYYkJHM0NtX1U1emw0bU1yYWNQQVRoVmxNMkg5QURMa1ZjekdJUlNKMm1iMWJybzN4OFctdDV2NkVKeFdsNm9zdG5FdE1yY0NwN3p5dWRUQm8?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQWnYzSjd3eWlsYTNJWVJ5NjZ1aEpBNWt4aDNFb3lGYi1PZ0w5UFlWQ2R4TU5BNTFfWC1DRUZKNnl3R29TaGZReFp2NUlmNXh4Vm5qbWxuU0EyY3h5OV9sXzhOZ0ljYnhqYWhMcGNXSXBIajZpQnE2aUhDTkRYYkJHM0NtX1U1emw0bU1yYWNQQVRoVmxNMkg5QURMa1ZjekdJUlNKMm1iMWJybzN4OFctdDV2NkVKeFdsNm9zdG5FdE1yY0NwN3p5dWRUQm8?oc=5", "title": "Tianjin Da Ren Tang Board Clears FY2026 Half-Year Reports and Governance Changes", "content_text": "Tianjin Da Ren Tang Board Clears FY2026 Half-Year Reports and Governance Changes", "date_published": "2026-08-14T10:52:17+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "T14"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"}]}}, {"id": "source:5b56587601c6c8b60a399d5d634e2dc268ee7d7b4daffc501a48016ab4c61fe2", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQZm9NZl9zbW5wRl9DYUU0LUNRRGRUZTc4V1JHSi16UUZhYVE5cHR6Zkh0LUlIUXNBY09QS2ZBdUNGODZDRGFHS2RTcWprLWRldEhudXk1ZTFxcktMbmpIdlVtUUZkY0RrNXRXRkFlcnF1VFUyWDZUS0R6bE8zUFN5VmJlQ1hJS1VzTExFYXBVaHZXNVZJN1haQVlyaWJGT0tUTnMtSFJ3T1FadERYNGF6eUJ4cUk0VC04b1ZULUJyUVI2RzFsWFV3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQZm9NZl9zbW5wRl9DYUU0LUNRRGRUZTc4V1JHSi16UUZhYVE5cHR6Zkh0LUlIUXNBY09QS2ZBdUNGODZDRGFHS2RTcWprLWRldEhudXk1ZTFxcktMbmpIdlVtUUZkY0RrNXRXRkFlcnF1VFUyWDZUS0R6bE8zUFN5VmJlQ1hJS1VzTExFYXBVaHZXNVZJN1haQVlyaWJGT0tUTnMtSFJ3T1FadERYNGF6eUJ4cUk0VC04b1ZULUJyUVI2RzFsWFV3?oc=5", "title": "Tianjin Pharmaceutical Da Ren Tang Updates Risk Review of Group Finance Unit", "content_text": "Tianjin Pharmaceutical Da Ren Tang Updates Risk Review of Group Finance Unit", "date_published": "2026-08-14T10:52:17+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "T14"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"}]}}, {"id": "source:a6e579e2532a371f6d00fab489a7b3d835f9610e85431a865f059194f5deb1b8", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQNGxhUjljZjBNNEl1Uk9XSmJlVEotajFJUjBkaVRwNUdfNS12SmVjVWpPeUpkTkxYZXZ4Z0dKWkh3ZWpjVWdfS0ZtNlhwYXl2YktzNVd0dWswalJ2RzZTRjRkZkpVQktMcFp6WFNRd2JPMTZWd2EtckZteVo1OEpuVWw0c1dnYy1maXBmRm1tUEtxangyNGowWkhIYldzb255RWFpdWNqcDE0NTZ0LTJ1bV9ZbmhPLVJvMjljNndtaFlRRXlQblJfcXdoQzZjaWdQR1ptQTNBOUZmNnVJ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQNGxhUjljZjBNNEl1Uk9XSmJlVEotajFJUjBkaVRwNUdfNS12SmVjVWpPeUpkTkxYZXZ4Z0dKWkh3ZWpjVWdfS0ZtNlhwYXl2YktzNVd0dWswalJ2RzZTRjRkZkpVQktMcFp6WFNRd2JPMTZWd2EtckZteVo1OEpuVWw0c1dnYy1maXBmRm1tUEtxangyNGowWkhIYldzb255RWFpdWNqcDE0NTZ0LTJ1bV9ZbmhPLVJvMjljNndtaFlRRXlQblJfcXdoQzZjaWdQR1ptQTNBOUZmNnVJ?oc=5", "title": "Tianjin Da Ren Tang Redirects Placement Proceeds to Working Capital After Project Cessations", "content_text": "Tianjin Da Ren Tang Redirects Placement Proceeds to Working Capital After Project Cessations", "date_published": "2026-08-14T10:50:28+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "T14"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"}]}}, {"id": "source:20f9748a7581a3cd058c49266163369ba2028596bc5fdf1cba45272f8aff7942", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOVE1YSlRtYXVmYTNuZjhPSXRGVm1laDNTWXVGaWgzRkdSblZ2eGd6VV9penkyczJiSVdrWW41R01kNXl5QUhidThLVjRrem9JT0M1NUhCV09Cd3o2b3laNG5DcjFRNERPS1VPMmQxRmI4UHNkQmc4cldOMDhIRHhCS0FHdXBCb2FSR1dOMVQ1bjI4Qk9IQmxsc0tTVXV1OTJQZjdiYWVpckxmTmtKZTJVcmpZbHJMMXk0RXoyLWhqdVlRSUlhS0FWbXQycnJ1dDNyTjF4TGlVdHNwWkdiVDc2TWJ4VW4?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOVE1YSlRtYXVmYTNuZjhPSXRGVm1laDNTWXVGaWgzRkdSblZ2eGd6VV9penkyczJiSVdrWW41R01kNXl5QUhidThLVjRrem9JT0M1NUhCV09Cd3o2b3laNG5DcjFRNERPS1VPMmQxRmI4UHNkQmc4cldOMDhIRHhCS0FHdXBCb2FSR1dOMVQ1bjI4Qk9IQmxsc0tTVXV1OTJQZjdiYWVpckxmTmtKZTJVcmpZbHJMMXk0RXoyLWhqdVlRSUlhS0FWbXQycnJ1dDNyTjF4TGlVdHNwWkdiVDc2TWJ4VW4?oc=5", "title": "Tianjin Pharmaceutical Da Ren Tang Board Clears Key Related-Party Distribution and Logistics Deals", "content_text": "Tianjin Pharmaceutical Da Ren Tang Board Clears Key Related-Party Distribution and Logistics Deals", "date_published": "2026-08-07T18:18:20+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "T14"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"}]}}, {"id": "source:9208211b0c0968440bcf26b71d6280fe8e1768b8424462091bb390b1583e0df6", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNX3pDVVRYS3JONzRRbGw4MFlfVl9YUmtyZUJzZmZFRmlXS3F6ZHdQZ1B4bjdTQ19hMlFVeVFUVHVpMFZKamZBYlRvam9Lenl5R3JaUFJURjVtdHF1NHF6eHBvMG1oeEU0YW1hVXVoTjJkZjE1Z3B3aWROeV80QTZxRUVnSVRic2FETVdsb3FtNUtrT3QwamxOYmo5TmhUZllsMUJkZzNBWFc2N2hRMXhiZWZhUGVOOUkzcGU4S1JhWno4ajQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNX3pDVVRYS3JONzRRbGw4MFlfVl9YUmtyZUJzZmZFRmlXS3F6ZHdQZ1B4bjdTQ19hMlFVeVFUVHVpMFZKamZBYlRvam9Lenl5R3JaUFJURjVtdHF1NHF6eHBvMG1oeEU0YW1hVXVoTjJkZjE1Z3B3aWROeV80QTZxRUVnSVRic2FETVdsb3FtNUtrT3QwamxOYmo5TmhUZllsMUJkZzNBWFc2N2hRMXhiZWZhUGVOOUkzcGU4S1JhWno4ajQ?oc=5", "title": "Tianjin Da Ren Tang Wins Approval for New Sustained-Release Diabetes Drug", "content_text": "Tianjin Da Ren Tang Wins Approval for New Sustained-Release Diabetes Drug", "date_published": "2026-08-07T17:05:45+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Regulatory and legal", "T14"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"}]}}, {"id": "source:b6075a7181d6ce41e9139ccaa7a6fe54ed6f1c89b16d28294a7afa4721e6dd43", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeXEtWVF2a2l3NmQ4alZzVWM3bndiUlBHT3RQVVJPVTI5blRkc1Z6TVVLYXphbngxRE1hZ3FmY0JBWC1NLWIydW9jSHB2WkMzbUwwX1BPLWhsVThyN3JsVTBWeFpHS1Y1QVhULWM3T210OXp2VFlQVXRXSl9BdTduazRmelR5Q19xcUc3ejFUVFUzOGpUNjcyWA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeXEtWVF2a2l3NmQ4alZzVWM3bndiUlBHT3RQVVJPVTI5blRkc1Z6TVVLYXphbngxRE1hZ3FmY0JBWC1NLWIydW9jSHB2WkMzbUwwX1BPLWhsVThyN3JsVTBWeFpHS1Y1QVhULWM3T210OXp2VFlQVXRXSl9BdTduazRmelR5Q19xcUc3ejFUVFUzOGpUNjcyWA?oc=5", "title": "Price to sales forward of iX Biopharma Ltd. \u2013 SGX:42C", "content_text": "Price to sales forward of iX Biopharma Ltd. \u2013 SGX:42C", "date_published": "2026-08-02T19:02:45+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:87e4e8e081deda328c9997676261fb810120f9de5a872dc7d0baaf9f3adf4510", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Ix Biopharma (Catalist:42C) Narrowing H1 EPS Loss Challenges Bearish Earnings Narratives", "content_text": "Ix Biopharma (Catalist:42C) Narrowing H1 EPS Loss Challenges Bearish Earnings Narratives", "date_published": "2026-05-10T07:00:00+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:6c5cf378bd659cb39e00256181bc111a01d865b02557d877577ff0671ed9075b", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOajFjSERHUnYtR3VyVTJ6enJxZFFIYmpFMmczNGhLa1pHRkZ4b1pBcHRwQy01SHpOaGtEdmE0ZUZlWHVIQkhES2dOM2dOYTEzSUpoVzAtU3FNRmhtVWdteXk4bjNvUjZOUi1HMF9STWkyclZyUW0yQmdfclVpejRWRG1xZXhVdXJFM1NOYnplVlFjbkRLdHBIcjZ5QVVHdFFQSElxV3N3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOajFjSERHUnYtR3VyVTJ6enJxZFFIYmpFMmczNGhLa1pHRkZ4b1pBcHRwQy01SHpOaGtEdmE0ZUZlWHVIQkhES2dOM2dOYTEzSUpoVzAtU3FNRmhtVWdteXk4bjNvUjZOUi1HMF9STWkyclZyUW0yQmdfclVpejRWRG1xZXhVdXJFM1NOYnplVlFjbkRLdHBIcjZ5QVVHdFFQSElxV3N3?oc=5", "title": "iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue", "content_text": "iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue", "date_published": "2026-02-10T08:00:00+00:00", "authors": [{"name": "Singapore Business Review"}], "tags": ["Earnings", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:8f7cef6b193b87f2f1fb5e35db0d8c5b004256cda392d8b5ef292bf24292cbca", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQRmNtMTdJNFJjcks3aHpoSkJYYzBCTU9QaGZUOUpmQzZWZmdDb3AwMkt6ZVF0U0I3dDVsQXdUWlBTenRXQUR0UW1UTnhUUXdZX1ZTQWN0VVMzRnpFM3VtTXVQQmo0eW5QSTcwWmJQNzZuMjJWdk1TYWJtYU9WVU1sR2xtUUkwUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQRmNtMTdJNFJjcks3aHpoSkJYYzBCTU9QaGZUOUpmQzZWZmdDb3AwMkt6ZVF0U0I3dDVsQXdUWlBTenRXQUR0UW1UTnhUUXdZX1ZTQWN0VVMzRnpFM3VtTXVQQmo0eW5QSTcwWmJQNzZuMjJWdk1TYWJtYU9WVU1sR2xtUUkwUQ?oc=5", "title": "iX Biopharma reports lower net loss for 1HFY2026", "content_text": "iX Biopharma reports lower net loss for 1HFY2026", "date_published": "2026-02-08T08:00:00+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:2c9798b22b077622edd7922c4f1d384833bb1756d5fa818e13cf9256ceb095e4", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3FkWG9mSHVvZUFPN0UwdzFHcGhTVmFPTzJ5dkZZQWhJdDRHUXMwQXYwSDR4eUIxUFJXRDlEOGRMMkt4VXpvTWNiMXM5WTZOUUs3S0ZFb1d6LWpyN2pCSWNRMnpxZU1jYURMNFlrdE5zUDloR3dOWkdadnFZQnNsSg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3FkWG9mSHVvZUFPN0UwdzFHcGhTVmFPTzJ5dkZZQWhJdDRHUXMwQXYwSDR4eUIxUFJXRDlEOGRMMkt4VXpvTWNiMXM5WTZOUUs3S0ZFb1d6LWpyN2pCSWNRMnpxZU1jYURMNFlrdE5zUDloR3dOWkdadnFZQnNsSg?oc=5", "title": "iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain", "content_text": "iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain", "date_published": "2025-12-31T08:00:00+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:732d8037e99c0476839d7fc4196bb48612bc9415098b1e515865677fe240a36b", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5uNVp2Q0cwRThleXk3U0F1MVlyX2NGNEhfLUNWZHRuYUNyV051R0FSWVJzSDd1ZlE5cjE2S3Vnd2FvRElnV3diUDU4NWZKZnlRLURlcVVkWktJTXdZQlQ4aV9NcXotdw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5uNVp2Q0cwRThleXk3U0F1MVlyX2NGNEhfLUNWZHRuYUNyV051R0FSWVJzSDd1ZlE5cjE2S3Vnd2FvRElnV3diUDU4NWZKZnlRLURlcVVkWktJTXdZQlQ4aV9NcXotdw?oc=5", "title": "Technical Analysis of iX Biopharma Ltd. (SGX:42C)", "content_text": "Technical Analysis of iX Biopharma Ltd. (SGX:42C)", "date_published": "2018-02-08T18:42:31+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:67a06a83a6b7bbea5db7403b7144558c8383284568d9da0e555abc34bba11005", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBaN3pTT01sS2VNcFVUQVB5SzZyZTZZNFZBTE85Z2g0cWFpUjlnQlBaWENEckdHRGt5Wk1BRXlJVGJocW5vM0RpLWI5azgtdUp2dWVyOA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBaN3pTT01sS2VNcFVUQVB5SzZyZTZZNFZBTE85Z2g0cWFpUjlnQlBaWENEckdHRGt5Wk1BRXlJVGJocW5vM0RpLWI5azgtdUp2dWVyOA?oc=5", "title": "iX Biopharma Ltd. (42C.SI) stock price, news, quote and history", "content_text": "iX Biopharma Ltd. (42C.SI) stock price, news, quote and history", "date_published": "2017-07-24T06:17:49+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:5269bc43d45fc5cb5f58a067c13aee788973875034f6882907ccc5965f073de8", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBMYTJCODRTM3N4S256VmUtbXU0dWh3cnBoeXA1SWdMemRFM1NjZ2VNYlBDUm15VnJRRFVBUnBISFA4ZndWdzhUR2luYm1pXzY3a2F1LUdXX0wySEJjT0hj?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBMYTJCODRTM3N4S256VmUtbXU0dWh3cnBoeXA1SWdMemRFM1NjZ2VNYlBDUm15VnJRRFVBUnBISFA4ZndWdzhUR2luYm1pXzY3a2F1LUdXX0wySEJjT0hj?oc=5", "title": "iX Biopharma Ltd. (42C.SI) stock major holders", "content_text": "iX Biopharma Ltd. (42C.SI) stock major holders", "date_published": "2017-06-12T17:28:31+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}, {"id": "source:ea1308297fd43732c9029c12560601d654b51de44f50382b7e1a1479cadc5943", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBhMkstZ2xwQW5VUko4U1AxTmhNakN2dG9IMGpRSkd6UlF5Q3lxUHRZWUpFTXl5SDJjNng2SWxDTVZaMkVFUlBNc1NZOS1PSUVOSGdFU0FxME1JV3RKbEsw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBhMkstZ2xwQW5VUko4U1AxTmhNakN2dG9IMGpRSkd6UlF5Q3lxUHRZWUpFTXl5SDJjNng2SWxDTVZaMkVFUlBNc1NZOS1PSUVOSGdFU0FxME1JV3RKbEsw?oc=5", "title": "iX Biopharma Ltd. (42C.SI) stock historical prices and data", "content_text": "iX Biopharma Ltd. (42C.SI) stock historical prices and data", "date_published": "2017-06-08T20:38:36+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "42C"], "_sharemaestro": {"country": "Singapore", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "42C", "name": "iX Biopharma Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/c86662db-2ab0-418e-82f6-6e483e75ab38/"}]}}]}